MLTX MoonLake Immunotherapeutics
Executive Summary
A cluster of 6 mega-passive institutional filers in MLTX shows a stark divergence: 3 small buyers (BofA, Wells Fargo, Morgan Stanley) added tiny positions totaling ~$1.9M in current value, while 3 massive sellers (BlackRock, Fidelity, T. Rowe Price) slashed holdings by a combined ~$280M. The net conviction is mixed but overwhelmingly bearish in dollar terms, driven by Fidelity's near-exit of a $270.5M position. This suggests passive rebalancing or risk reduction rather than a shared fundamental thesis, but the scale of selling dwarfs buying by over 100:1.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$278.0M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +493.6% | $1.8M | -$200.7K |
| Wells Fargo | DOUBLED | +618.3% | $37.0K | $3.0K |
| BofA | ADD | +64.7% | $32.0K | -$97.4K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Fidelity | NEAR_EXIT | -87.3% | $270.5M | -$265.3M |
| BlackRock | TRIM | -61.7% | $15.5M | -$14.6M |
| T. Rowe Price | TRIM | -68.5% | $123.0K | -$117.4K |
Actionable Insight
The massive passive selling (especially Fidelity's near-exit) suggests index rebalancing or risk-off rotation, not a fundamental thesis. Monitor next 13F for further passive outflows and any active-manager entries that could signal a contrarian opportunity. The 77% analyst bullish consensus stands in sharp contrast to this institutional exit — a divergence that often precedes further downside if fundamentals disappoint.
Key Facts
- 3 buyers added $1.9M in current holdings; 3 sellers reduced by $279.9M — net selling of ~$278M
- Fidelity nearly exited: sold 5.0M shares, reducing a $270.5M position to $5.2M (87.3% trim)
- BlackRock trimmed 61.7% of its stake, selling $14.6M worth
- T. Rowe Price trimmed 68.5% of its stake, selling $117K worth
- All 6 filers are mega-passive (index/rebalance-driven), not active managers — weakens signal of a shared thesis
- Morgan Stanley doubled its position but the dollar value actually fell by $200K due to price decline
Financial Impact
3 passive institutions sold a combined $279.9M in MLTX stock during Q3 2025, while 3 others bought only $1.9M — a net outflow of ~$278M, representing roughly 21% of the company's $1.3B market cap
Risk Factors
- Passive selling may continue if MLTX is being removed from indices or if market-cap thresholds are breached
- The 45-day reporting lag means these Q3 positions may already be fully unwound — current ownership could be even lower
- Analyst consensus is heavily bullish (77% buy), creating potential for negative surprises if institutional selling reflects non-public concerns
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MLTX-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $17.99 awaiting T+5 | awaiting T+5 | — | — |
|
Jun 1, 2026
12d ago
|
8-K
| $18.82 $17.90 | ▼ −4.89% | ▼ −2.14% | — |
|
May 10, 2026
4w ago
|
Press Release
| $18.84 $16.44 | ▼ −12.74% | ▼ −12.65% | — |
|
Apr 1, 2026
10w ago
|
144
| $16.52 $19.41 | ▼ −17.49% | ▼ −13.73% | — |
|
Mar 28, 2026
10w ago
|
Press Release
| $16.93 $17.08 | ▲ +0.89% | ▼ −3.41% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access